Independent Portfolio Consultants’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$33K Sell
444
-30
-6% -$2.23K 0.01% 566
2017
Q1
$35K Sell
474
-369
-44% -$25.8K 0.01% 607
2016
Q4
$55K Sell
843
-259
-24% -$17.8K 0.02% 538
2016
Q3
$82K Hold
1,102
0.03% 465
2016
Q2
$81K Hold
1,102
0.03% 477
2016
Q1
$78K Sell
1,102
-330
-23% -$22K 0.02% 508
2015
Q4
$95K Buy
1,432
+275
+24% +$18.3K 0.03% 486
2015
Q3
$73K Sell
1,157
-140
-11% -$9.15K 0.02% 517
2015
Q2
$85K Buy
1,297
+180
+16% +$12.2K 0.02% 524
2015
Q1
$77K Sell
1,117
-305
-21% -$21.1K 0.02% 533
2014
Q4
$98K Buy
1,422
+70
+5% +$4.73K 0.02% 511
2014
Q3
$88K Buy
1,352
+222
+20% +$14.6K 0.02% 569
2014
Q2
$77K Buy
+1,130
New +$75.7K 0.02% 563
2014
Q1
Sell
-3,665
Closed -$239K 455
2013
Q4
$239K Buy
3,665
+285
+8% +$18.2K 0.08% 409
2013
Q3
$200K Buy
+3,380
New +$200K 0.08% 422

Other funds holding CL

Independent Portfolio Consultants's CL Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Colgate-Palmolive (CL) stake by 6.3% in Q2 2017, selling an estimated $2.23K and leaving 444 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #566.

Independent Portfolio Consultants first reported a position in CL in Q3 2013 and has held it in 15 quarters since. The position peaked at $239K in Q4 2013. 1,370 funds tracked by Wall St. Rank hold CL as of Q2 2017.

  • Independent Portfolio Consultants held 444 shares of Colgate-Palmolive worth $33K as of Q2 2017.
  • Independent Portfolio Consultants sold 30 Colgate-Palmolive shares in Q2 2017, an estimated $2.23K.
  • Colgate-Palmolive made up 0.01% of Independent Portfolio Consultants's portfolio in Q2 2017, its #566 holding.
  • Independent Portfolio Consultants first reported a position in Colgate-Palmolive in Q3 2013 and has held it in 15 quarters since.
  • Independent Portfolio Consultants's Colgate-Palmolive position peaked at $239K in Q4 2013.
  • 1,370 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.